I Gilron

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain
    I Gilron
    Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892 1258, USA
    Clin Pharmacol Ther 68:320-7. 2000
  2. ncbi Pre- versus postinjury effects of intravenous GABAergic anesthetics on formalin-induced Fos immunoreactivity in the rat spinal cord
    I Gilron
    National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA
    Anesth Analg 88:414-20. 1999
  3. ncbi Pre- versus postformalin effects of ketamine or large-dose alfentanil in the rat: discordance between pain behavior and spinal Fos-like immunoreactivity
    I Gilron
    Pain Research Clinic, Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA
    Anesth Analg 89:128-35. 1999
  4. ncbi Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study
    I Gilron
    Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892-1258, USA
    Clin Neuropharmacol 24:109-12. 2001

Detail Information

Publications4

  1. ncbi Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain
    I Gilron
    Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892 1258, USA
    Clin Pharmacol Ther 68:320-7. 2000
    ..Previous studies suggest that 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid (AMPA)/kainate antagonists reduce experimentally induced pain. There have been no studies of AMPA/kainate antagonists in clinical pain...
  2. ncbi Pre- versus postinjury effects of intravenous GABAergic anesthetics on formalin-induced Fos immunoreactivity in the rat spinal cord
    I Gilron
    National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA
    Anesth Analg 88:414-20. 1999
    ..Fos inhibition patterns were inconsistent with behavioral studies of these anesthetics, suggesting that Fos inhibition does not always correlate with behavioral analgesia...
  3. ncbi Pre- versus postformalin effects of ketamine or large-dose alfentanil in the rat: discordance between pain behavior and spinal Fos-like immunoreactivity
    I Gilron
    Pain Research Clinic, Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA
    Anesth Analg 89:128-35. 1999
    ..Fos inhibition patterns did not clearly correlate with pain reduction, providing further evidence that Fos inhibition is not always predictive of behavioral analgesia...
  4. ncbi Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study
    I Gilron
    Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892-1258, USA
    Clin Neuropharmacol 24:109-12. 2001
    ..Larger trials are needed to more precisely estimate the effect of topiramate in trigeminal neuralgia...